Dystonia clinical trials

Explore recruiting dystonia clinical trials.

Recruiting dystonia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Dystonia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Selän alueen poikkeava aktiivisuus servikaalisessa dystoniassa

Finland

Therapeutic use (Phase IV) EU CTIS Study details

A Phase II, Multicentre, Randomised, Double-blind, Parallel-Group, Placebo controlled Study to Evaluate the Efficacy and Safety of IPN10200 as a Treatment for Cervical Dystonia in Adult Participants

Czechia, Germany, Poland, France, Italy, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy

Portugal, Belgium, Spain, Italy, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Factors Determining the Efficacy of Botulinum Toxin for Arm Tremor in Dystonia: An Exploratory Study

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Prospective pilot trial to address the feasibility and safety of treatment with oral Zinc in GNAO1 associated disorders (ZINCGNAO1)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

The effect of amantadine as add-on therapy for motor fluctuations in advanced Parkinson’s disease: a randomized double-blinded placebo-controlled trial

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Dystonia trials by city

Dystonia in Toronto Dystonia in Vancouver Dystonia in Montreal Dystonia in Calgary Dystonia in Edmonton Dystonia in Ottawa Dystonia in Winnipeg Dystonia in Quebec City Dystonia in Hamilton Dystonia in Kitchener Dystonia in London Dystonia in Halifax Dystonia in New York Dystonia in Los Angeles Dystonia in Chicago Dystonia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease